Susquehanna International Group
CUE icon

Susquehanna International Group’s Cue Biopharma CUE Stock Holding History

Susquehanna International Group’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-373
Closed -$12.2K – 12613
2024
Q4 		$12.2K Buy
+373
New +$14K ﹤0.01% 11971
2024
Q3 		– Sell
-1,443
Closed -$53.7K – 12136
2024
Q2 		$53.7K Buy
+1,443
New +$71.4K ﹤0.01% 11381
2024
Q1 		– Sell
-2,530
Closed -$200K – 12340
2023
Q4 		$200K Buy
+2,530
New +$181K ﹤0.01% 10683
2023
Q1 		– Sell
-980
Closed -$83.8K – 12677
2022
Q4 		$83.8K Buy
980
+390
+66% +$35.7K ﹤0.01% 11096
2022
Q3 		$39K Buy
590
+23
+4% +$1.98K ﹤0.01% 12343
2022
Q2 		$42K Sell
567
-3,430
-86% -$401K ﹤0.01% 12068
2022
Q1 		$585K Buy
3,997
+1,397
+54% +$296K ﹤0.01% 8572
2021
Q4 		$882K Sell
2,600
-107
-4% -$41.4K ﹤0.01% 7619
2021
Q3 		$1.18M Buy
2,707
+1,594
+143% +$556K ﹤0.01% 7116
2021
Q2 		$389K Buy
1,113
+700
+169% +$271K ﹤0.01% 10202
2021
Q1 		$151K Buy
+413
New +$170K ﹤0.01% 11650
2020
Q4 		– Sell
-553
Closed -$250K – 11086
2020
Q3 		$250K Sell
553
-1,004
-64% -$579K ﹤0.01% 9066
2020
Q2 		$1.15M Buy
+1,557
New +$1.13M ﹤0.01% 5604

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $2.19B AUM 23.13% 1-Year Est. Return

Susquehanna International Group's CUE Position: Q1 2026 in Review

Susquehanna International Group reduced its Cue Biopharma (CUE) stake by 85% in Q1 2026, selling an estimated $44.9K and leaving 820 shares worth $5.66K. The position accounts for ﹤0.01% of the portfolio, ranked #12979.

Susquehanna International Group first reported a position in CUE in Q2 2020 and has held it in 21 quarters since. The position peaked at $689K in Q1 2021. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.

  • Susquehanna International Group held 820 shares of Cue Biopharma worth $5.66K as of Q1 2026.
  • Susquehanna International Group sold 4,808 Cue Biopharma shares in Q1 2026, an estimated $44.9K.
  • Cue Biopharma made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12979 holding.
  • Susquehanna International Group first reported a position in Cue Biopharma in Q2 2020 and has held it in 21 quarters since.
  • Susquehanna International Group's Cue Biopharma position peaked at $689K in Q1 2021.
  • 55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.